Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB-DYYB Cause Condition aggravated? 10,275 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 10,275 reports of Condition aggravated have been filed in association with INFLIXIMAB-DYYB (ZYMFENTRA). This represents 40.2% of all adverse event reports for INFLIXIMAB-DYYB.

10,275
Reports of Condition aggravated with INFLIXIMAB-DYYB
40.2%
of all INFLIXIMAB-DYYB reports
163
Deaths
3,133
Hospitalizations

How Dangerous Is Condition aggravated From INFLIXIMAB-DYYB?

Of the 10,275 reports, 163 (1.6%) resulted in death, 3,133 (30.5%) required hospitalization, and 56 (0.5%) were considered life-threatening.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB-DYYB. However, 10,275 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB-DYYB Cause?

Off label use (14,256) Intentional product use issue (7,549) Inappropriate schedule of product administration (5,977) Arthralgia (4,615) Drug ineffective (3,112) Fatigue (3,111) Weight increased (2,848) Malaise (2,766) Weight decreased (2,703) Blood pressure increased (2,309)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627) TOCILIZUMAB (8,471)

Which INFLIXIMAB-DYYB Alternatives Have Lower Condition aggravated Risk?

INFLIXIMAB-DYYB vs INFLIXIMAB-QBTX INFLIXIMAB-DYYB vs INFLIXIMAB, RECOMBINANT INFLIXIMAB-DYYB vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B

Related Pages

INFLIXIMAB-DYYB Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated INFLIXIMAB-DYYB Demographics